论文部分内容阅读
卵巢癌是死亡率最高的妇科恶性肿瘤,其发病隐匿,进展迅速,70%~80%的卵巢癌患者发现时已属晚期。卵巢癌肿瘤细胞减灭术后腹腔内热灌注化疗不失为一种治疗进展期及复发性卵巢癌患者的有效措施之一,能增加局部肿瘤组织中化疗药物的浓度,降低肿瘤细胞对化疗药物的耐药性与化疗药物的全身毒副反应,减轻患者的腹水症状,显著改善患者生存质量及提高患者生存率,引起了临床医生们的很大兴趣和广泛研究。
Ovarian cancer is the highest mortality of gynecologic malignancies, its incidence hiding, rapid progress, 70% to 80% of ovarian cancer patients have been found late. Intraperitoneal hyperthermic perfusion chemotherapy after ovarian cancer cytoreductive surgery is one of the effective measures to treat patients with advanced and recurrent ovarian cancer, which can increase the concentration of chemotherapeutic drugs in local tumor tissues and reduce the drug resistance of tumor cells to chemotherapeutic drugs Sexual and chemotherapeutic drugs systemic side effects, reduce the patient’s symptoms of ascites, significantly improve the quality of life of patients and improve patient survival rate, aroused great interest and extensive research by clinicians.